Illumina, Inc. is a prominent global leader in the biotechnology sector, headquartered in San Diego, California, and established in 1998. The company is renowned for its cutting-edge technologies and integrated systems for genomic analysis, with a strong focus on sequencing, genotyping, and gene expression solutions. Illumina's diverse product offerings cater to various markets, including research, clinical diagnostics, and agricultural genomics, significantly advancing the field of personalized medicine. With a steadfast commitment to enhancing human health through innovation, Illumina continues to drive breakthroughs in genetic research and diagnostics, solidifying its position as a pivotal player in the genomics landscape.